Literature DB >> 9875540

Alz-50/Gallyas-positive lysosome-like intraneuronal granules in Alzheimer's disease and control brains.

K Ikeda1, H Akiyama, T Arai, H Kondo, C Haga, S Iritani, K Tsuchiya.   

Abstract

The Gallyas-Braak silver impregnation method revealed neurons containing well-defined intraneuronal granules in both Alzheimer's disease and normal control brains. The granules were immunostained prominently with the Alz-50 antibody and, to a lesser degree, with the tau-2 antibody, but not with other anti-tau antibodies examined. The areas of distribution of granule-containing neurons detected by the Gallyas-Braak method appeared to overlap with the reported main sites of subcortical distribution of neurofibrillary tangles. They, however, were not observed in the cerebral cortex, including the hippocampal region. The Alz-50 immunoreactive granules showed ultrastructural features similar to those of lysosomes or lipofuscin. These findings suggest that denatured tau might be degraded in lysosomes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9875540     DOI: 10.1016/s0304-3940(98)00867-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

1.  Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo.

Authors:  Erin E Congdon; Jessica W Wu; Natura Myeku; Yvette H Figueroa; Mathieu Herman; Paul S Marinec; Jason E Gestwicki; Chad A Dickey; W Haung Yu; Karen E Duff
Journal:  Autophagy       Date:  2012-04-01       Impact factor: 16.016

2.  Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain.

Authors:  Allal Boutajangout; Johanna Ingadottir; Peter Davies; Einar M Sigurdsson
Journal:  J Neurochem       Date:  2011-07-01       Impact factor: 5.372

3.  Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model.

Authors:  Allal Boutajangout; David Quartermain; Einar M Sigurdsson
Journal:  J Neurosci       Date:  2010-12-08       Impact factor: 6.167

Review 4.  Autophagy: a double-edged sword in Alzheimer's disease.

Authors:  Ying-Tsen Tung; Bo-Jeng Wang; Ming-Kuan Hu; Wen-Ming Hsu; Hsinyu Lee; Wei-Pang Huang; Yung-Feng Liao
Journal:  J Biosci       Date:  2012-03       Impact factor: 1.826

Review 5.  Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases.

Authors:  Gouri Chopra; Shabnam Shabir; Sumaira Yousuf; Simran Kauts; Shahnawaz A Bhat; Ashiq H Mir; Mahendra P Singh
Journal:  Mol Neurobiol       Date:  2022-10-07       Impact factor: 5.682

6.  Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing.

Authors:  Yipeng Wang; Marta Martinez-Vicente; Ulrike Krüger; Susmita Kaushik; Esther Wong; Eva-Maria Mandelkow; Ana Maria Cuervo; Eckhard Mandelkow
Journal:  Hum Mol Genet       Date:  2009-08-04       Impact factor: 6.150

7.  Lysosomal fusion dysfunction as a unifying hypothesis for Alzheimer's disease pathology.

Authors:  Kristen E Funk; Jeff Kuret
Journal:  Int J Alzheimers Dis       Date:  2012-08-30

8.  Mechanistic Studies of Antibody-Mediated Clearance of Tau Aggregates Using an ex vivo Brain Slice Model.

Authors:  Pavan K Krishnamurthy; Yan Deng; Einar M Sigurdsson
Journal:  Front Psychiatry       Date:  2011-10-21       Impact factor: 4.157

9.  Neuroglia in the inferior olivary nucleus during normal aging and Alzheimer's disease.

Authors:  H Lasn; B Winblad; N Bogdanovic
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

10.  β-Secretase 1's Targeting Reduces Hyperphosphorilated Tau, Implying Autophagy Actors in 3xTg-AD Mice.

Authors:  Diego Piedrahita; John Fredy Castro-Alvarez; Ryan L Boudreau; Andres Villegas-Lanau; Kenneth S Kosik; Juan Carlos Gallego-Gomez; Gloria Patricia Cardona-Gómez
Journal:  Front Cell Neurosci       Date:  2016-01-08       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.